Fresh Recalls

FDAClass II · Drug · Recall D-0733-2026 · Recalled August 12, 2026

Dicyclomine Hydrochloride Capsules recall — Aurobindo Pharma USA Inc

Agency report date: August 12, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Dicyclomine Hydrochloride Capsules
Company / brand
Aurobindo Pharma USA
Lot / serial / date codes
Batch # DMC125018A, Exp Date: 07/2027.
Distribution
US Nationwide.
Agency product description and boundaries

Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: shortfill; reports of empty capsules.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Dicyclomine Hydrochloride Capsules

3. Open the official notice or contact

Official recall ID
D-0733-2026
Brand
Aurobindo Pharma USA
Classification
Class II
Units affected
6,408 bottles distributed to market
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
East Windsor, NJ, United States
Firm address
279 Princeton Hightstown Rd, 08520-1401

Identifying details (verbatim from the notice)

Product codes / lots
Batch # DMC125018A, Exp Date: 07/2027.
Distribution
US Nationwide.
Firm notified the public via
Letter
FDA event ID
99492
Recall initiated
July 23, 2026
FDA classified
August 4, 2026
FDA report date
August 12, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page